Development of an innovative nanostructured dermal matrix in combination with a hyperstable form of growth factor for fibroblasts (FGF2): Ex ovo and in vivo study
Development of an innovative nanostructured dermal matrix in combination with a hyperstable form of growth factor for fibroblasts (FGF2): Ex ovo and in vivo study
HOLOUBEK, Jakub; Břetislav LIPOVÝ; Martin KNOZ; Lucy VOJTOVÁ; Johana BABRNÁKOVÁ; Veronika PAVLINAKOVA; Lucie VISTEJNOVA; Veronika ŠTĚPÁNKOVÁ; Eva FILOVA; Zdeněk PAVLOVSKÝ; Martin FALDYNA; Eduard GÖPFERT; Jiří DAMBORSKÝ a Vanessa HEARNDEN. Development of an innovative nanostructured dermal matrix in combination with a hyperstable form of growth factor for fibroblasts (FGF2): Ex ovo and in vivo study. In 10th Congress of World Society for Reconstructive Microsurgery, Bologna, Italy. 2019.
@proceedings{1544363, author = {Holoubek, Jakub and Lipový, Břetislav and Knoz, Martin and Vojtová, Lucy and Babrnáková, Johana and Pavlinakova, Veronika and Vistejnova, Lucie and Štěpánková, Veronika and Filova, Eva and Pavlovský, Zdeněk and Faldyna, Martin and Göpfert, Eduard and Damborský, Jiří and Hearnden, Vanessa}, booktitle = {10th Congress of World Society for Reconstructive Microsurgery, Bologna, Italy}, title = {Development of an innovative nanostructured dermal matrix in combination with a hyperstable form of growth factor for fibroblasts (FGF2): Ex ovo and in vivo study}, year = {2019} }
TY - CONF ID - 1544363 AU - Holoubek, Jakub - Lipový, Břetislav - Knoz, Martin - Vojtová, Lucy - Babrnáková, Johana - Pavlinakova, Veronika - Vistejnova, Lucie - Štěpánková, Veronika - Filova, Eva - Pavlovský, Zdeněk - Faldyna, Martin - Göpfert, Eduard - Damborský, Jiří - Hearnden, Vanessa PY - 2019 TI - Development of an innovative nanostructured dermal matrix in combination with a hyperstable form of growth factor for fibroblasts (FGF2): Ex ovo and in vivo study ER -
HOLOUBEK, Jakub; Břetislav LIPOVÝ; Martin KNOZ; Lucy VOJTOVÁ; Johana BABRNÁKOVÁ; Veronika PAVLINAKOVA; Lucie VISTEJNOVA; Veronika ŠTĚPÁNKOVÁ; Eva FILOVA; Zdeněk PAVLOVSKÝ; Martin FALDYNA; Eduard GÖPFERT; Jiří DAMBORSKÝ a Vanessa HEARNDEN. Development of an innovative nanostructured dermal matrix in combination with a hyperstable form of growth factor for fibroblasts (FGF2): Ex ovo and in vivo study. In \textit{10th Congress of World Society for Reconstructive Microsurgery, Bologna, Italy}. 2019.